FWP
BSX icon

Forefront Wealth Partners’s Boston Scientific BSX Stock Holding History

Forefront Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,499
Closed -$408K – 178
2026
Q1 		$408K Buy
6,499
+4,274
+192% +$342K 0.17% 109
2025
Q4 		$212K Buy
2,225
+118
+6% +$11.6K 0.1% 133
2025
Q3 		$206K Buy
+2,107
New +$218K 0.05% 183

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Forefront Wealth Partners's BSX Position: Q2 2026 in Review

Forefront Wealth Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 6,499 shares — an estimated $408K sold.

Forefront Wealth Partners first reported a position in BSX in Q3 2025 and held it in 3 quarters. The position peaked at $408K in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Forefront Wealth Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Forefront Wealth Partners sold 6,499 Boston Scientific shares in Q2 2026, an estimated $408K.
  • Forefront Wealth Partners first reported a position in Boston Scientific in Q3 2025 and held it in 3 quarters.
  • Forefront Wealth Partners's Boston Scientific position peaked at $408K in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Forefront Wealth Partners's 13F filing for Q2 2026, filed 20 Aug 2026.